Lian Duan


Country: China


  1. Liu P, Han C, Li D, Lv X, Li Y, Duan L. Hemorrhagic Moyamoya Disease in Children: Clinical, Angiographic features, and Long-Term Surgical Outcome. Stroke. 2016;47:240-3 pubmed publisher
    ..The encephalo-duro-arterio-synangiosis surgery can effectively increase the cerebral blood flow in children, which may decrease the incidence of recurrent hemorrhage. ..
  2. Bao X, Wang Q, Zhang Y, Zhang Q, Li D, Yang W, et al. Epidemiology of Moyamoya Disease in China: Single-Center, Population-Based Study. World Neurosurg. 2018;: pubmed publisher
    ..As a lack of national epidemiologic studies, this study indicated the outline of moyamoya in China. ..
  3. Duan L, Bao X, Yang W, Shi W, Li D, Zhang Z, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke. 2012;43:56-60 pubmed publisher
    ..Patients had low rates of postoperative ischemic or hemorrhagic strokes, and the majority of patients had preserved functional status after revascularization. ..
  4. Han C, Yang W, Zhang H, Ye T, Duan L. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1. J Clin Neurosci. 2015;22:286-90 pubmed publisher
    ..Revascularization surgery may prevent the progression of clinical symptoms and reduce the risk of subsequent strokes. ..
  5. Karunanithi K, Han C, Lee C, Shi W, Duan L, Qian Y. Identification of a hemodynamic parameter for assessing treatment outcome of EDAS in Moyamoya disease. J Biomech. 2015;48:304-9 pubmed publisher
    ..This elucidates that our findings have instituted a new parameter that may well play a critical role as an assistive clinical decision making tool in MMD. ..
  6. Bao X, Zhang Y, Wang Q, Zhang Q, Wang H, Zhang Z, et al. Long-term Outcomes After Encephaloduroarteriosynangiosis in Adult Patients with Moyamoya Disease Presenting with Ischemia. World Neurosurg. 2018;115:e482-e489 pubmed publisher
    ..EDAS is an effective procedure in a Chinese cohort of patients with MMD. EDAS resulted in satisfactory long-term improvement of clinical states and prevention of recurrent strokes. ..
  7. Liu P, Lv X, Liu A, Chen C, Ge H, Jin H, et al. Intracranial Aneurysms Associated with Moyamoya Disease in Children: Clinical Features and Long-Term Surgical Outcome. World Neurosurg. 2016;94:513-520 pubmed publisher
  8. Liu P, Liu A, Han C, Chen C, Lv X, Li D, et al. Difference in Angiographic Characteristics Between Hemorrhagic And Nonhemorrhagic Hemispheres Associated with Hemorrhage Risk of Moyamoya Disease in Adults: A Self-Controlled Study. World Neurosurg. 2016;95:348-356 pubmed publisher
    ..Longer and more detailed clinical and angiographic follow-up are still needed to delineate the specific mechanism underlying the recurrent hemorrhage in hemorrhagic MMD. ..
  9. Han C, Li M, Xu Y, Ye T, Xie C, Gao S, et al. Adult moyamoya-atherosclerosis syndrome: Clinical and vessel wall imaging features. J Neurol Sci. 2016;369:181-184 pubmed publisher
    ..The distinct clinical features between MMD-P and MMD-NP patients suggest different underlying pathophysiology and therefore potentially different treatment strategies. ..

More Information


  1. Qiao P, Han C, Zuo Z, Wang Y, Pfeuffer J, Duan L, et al. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study. J Neuroradiol. 2017;44:273-280 pubmed publisher
    ..And mTI-ASL is more advantageous because it does not require contrast agents. ..
  2. Qiao P, Zuo Z, Han C, Zhou J, Zhang H, Duan L, et al. Cortical thickness changes in adult moyamoya disease assessed by structural magnetic resonance imaging. Clin Imaging. 2017;46:71-77 pubmed publisher
    ..CVA scores were negatively correlated with the average cortical thicknesses. Cortical thickness can be used as a biological indicator to assess the severity of MMD. ..